/
INMD
$15.20-$0.03 (-0.20%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$876.4M
58M shares
52-week range
$12.72 – $16.74
62% from low
Exchange
NASDAQ
CS
Change$-37.31
InMode Ltd. Ordinary Shares
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
www.inmodemd.com- Employees
- 660
- IPO / List date
- Aug 8, 2019
Held by traders on TradeandTell
No one on the platform currently holds INMD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 2,586,218 | $35.4M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2021-10-01 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded INMD yet.
